Selected research
Industry Research
Pleural Effusions Treatment Industry Research Report 2026
Market perspective
The global Pleural Effusions Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pleural Effusions Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pleural Effusions Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pleural Effusions Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pleural Effusions Treatment include Shyndec Pharmaceutical, Lepu Medical, B. Braun, Balance Medical, Smith Medical, Redax, Oakworks Medical, Nouvag and Maxer, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pleural Effusions Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pleural Effusions Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pleural Effusions Treatment Market by Company
Shyndec Pharmaceutical
Lepu Medical
B. Braun
Balance Medical
Smith Medical
Redax
Oakworks Medical
Nouvag
Maxer
Heyer Medical
Grena
Biometrix
Bicakcilar
Pleural Effusions Treatment Segment by Type
Thoracentesis
Pleurodesis
Pleuroperitoneal Shunt
Pleural Effusions Treatment Segment by Application
Hospitals
Clinics
Others
Pleural Effusions Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pleural Effusions Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pleural Effusions Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pleural Effusions Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pleural Effusions Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Thoracentesis
- Pleurodesis
- Pleuroperitoneal Shunt
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Shyndec Pharmaceutical
- Lepu Medical
- B. Braun
- Balance Medical
- Smith Medical
- Redax
- Oakworks Medical
- Nouvag
- Maxer
- Heyer Medical
- Grena
- Biometrix
- Bicakcilar
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pleural Effusions Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Thoracentesis
- 2.2.3 Pleurodesis
- 2.2.4 Pleuroperitoneal Shunt
- 2.3 Pleural Effusions Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Clinics
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Pleural Effusions Treatment Breakdown Data by Type
- 3.1 Global Pleural Effusions Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Pleural Effusions Treatment Forecasted Market Size by Type (2027-2032)
4 Pleural Effusions Treatment Breakdown Data by Application
- 4.1 Global Pleural Effusions Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Pleural Effusions Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pleural Effusions Treatment Market Perspective (2021-2032)
- 5.2 Global Pleural Effusions Treatment Growth Trends by Region
- 5.2.1 Global Pleural Effusions Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pleural Effusions Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Pleural Effusions Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Pleural Effusions Treatment Market Dynamics
- 5.3.1 Pleural Effusions Treatment Industry Trends
- 5.3.2 Pleural Effusions Treatment Market Drivers
- 5.3.3 Pleural Effusions Treatment Market Challenges
- 5.3.4 Pleural Effusions Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pleural Effusions Treatment Players by Revenue
- 6.1.1 Global Top Pleural Effusions Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Pleural Effusions Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Pleural Effusions Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pleural Effusions Treatment Head Office and Area Served
- 6.4 Global Pleural Effusions Treatment Players, Product Type & Application
- 6.5 Global Pleural Effusions Treatment Manufacturers Established Date
- 6.6 Global Pleural Effusions Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pleural Effusions Treatment Market Size (2021-2032)
- 7.2 North America Pleural Effusions Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pleural Effusions Treatment Market Size by Country (2021-2026)
- 7.4 North America Pleural Effusions Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pleural Effusions Treatment Market Size (2021-2032)
- 8.2 Europe Pleural Effusions Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pleural Effusions Treatment Market Size by Country (2021-2026)
- 8.4 Europe Pleural Effusions Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pleural Effusions Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Pleural Effusions Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pleural Effusions Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pleural Effusions Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pleural Effusions Treatment Market Size (2021-2032)
- 10.2 South America Pleural Effusions Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pleural Effusions Treatment Market Size by Country (2021-2026)
- 10.4 South America Pleural Effusions Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pleural Effusions Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Pleural Effusions Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pleural Effusions Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pleural Effusions Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Shyndec Pharmaceutical
- 12.1.1 Shyndec Pharmaceutical Company Information
- 12.1.2 Shyndec Pharmaceutical Business Overview
- 12.1.3 Shyndec Pharmaceutical Revenue in Pleural Effusions Treatment Business (2021-2026)
- 12.1.4 Shyndec Pharmaceutical Pleural Effusions Treatment Product Portfolio
- 12.1.5 Shyndec Pharmaceutical Recent Developments
- 12.2 Lepu Medical
- 12.2.1 Lepu Medical Company Information
- 12.2.2 Lepu Medical Business Overview
- 12.2.3 Lepu Medical Revenue in Pleural Effusions Treatment Business (2021-2026)
- 12.2.4 Lepu Medical Pleural Effusions Treatment Product Portfolio
- 12.2.5 Lepu Medical Recent Developments
- 12.3 B. Braun
- 12.3.1 B. Braun Company Information
- 12.3.2 B. Braun Business Overview
- 12.3.3 B. Braun Revenue in Pleural Effusions Treatment Business (2021-2026)
- 12.3.4 B. Braun Pleural Effusions Treatment Product Portfolio
- 12.3.5 B. Braun Recent Developments
- 12.4 Balance Medical
- 12.4.1 Balance Medical Company Information
- 12.4.2 Balance Medical Business Overview
- 12.4.3 Balance Medical Revenue in Pleural Effusions Treatment Business (2021-2026)
- 12.4.4 Balance Medical Pleural Effusions Treatment Product Portfolio
- 12.4.5 Balance Medical Recent Developments
- 12.5 Smith Medical
- 12.5.1 Smith Medical Company Information
- 12.5.2 Smith Medical Business Overview
- 12.5.3 Smith Medical Revenue in Pleural Effusions Treatment Business (2021-2026)
- 12.5.4 Smith Medical Pleural Effusions Treatment Product Portfolio
- 12.5.5 Smith Medical Recent Developments
- 12.6 Redax
- 12.6.1 Redax Company Information
- 12.6.2 Redax Business Overview
- 12.6.3 Redax Revenue in Pleural Effusions Treatment Business (2021-2026)
- 12.6.4 Redax Pleural Effusions Treatment Product Portfolio
- 12.6.5 Redax Recent Developments
- 12.7 Oakworks Medical
- 12.7.1 Oakworks Medical Company Information
- 12.7.2 Oakworks Medical Business Overview
- 12.7.3 Oakworks Medical Revenue in Pleural Effusions Treatment Business (2021-2026)
- 12.7.4 Oakworks Medical Pleural Effusions Treatment Product Portfolio
- 12.7.5 Oakworks Medical Recent Developments
- 12.8 Nouvag
- 12.8.1 Nouvag Company Information
- 12.8.2 Nouvag Business Overview
- 12.8.3 Nouvag Revenue in Pleural Effusions Treatment Business (2021-2026)
- 12.8.4 Nouvag Pleural Effusions Treatment Product Portfolio
- 12.8.5 Nouvag Recent Developments
- 12.9 Maxer
- 12.9.1 Maxer Company Information
- 12.9.2 Maxer Business Overview
- 12.9.3 Maxer Revenue in Pleural Effusions Treatment Business (2021-2026)
- 12.9.4 Maxer Pleural Effusions Treatment Product Portfolio
- 12.9.5 Maxer Recent Developments
- 12.10 Heyer Medical
- 12.10.1 Heyer Medical Company Information
- 12.10.2 Heyer Medical Business Overview
- 12.10.3 Heyer Medical Revenue in Pleural Effusions Treatment Business (2021-2026)
- 12.10.4 Heyer Medical Pleural Effusions Treatment Product Portfolio
- 12.10.5 Heyer Medical Recent Developments
- 12.11 Grena
- 12.11.1 Grena Company Information
- 12.11.2 Grena Business Overview
- 12.11.3 Grena Revenue in Pleural Effusions Treatment Business (2021-2026)
- 12.11.4 Grena Pleural Effusions Treatment Product Portfolio
- 12.11.5 Grena Recent Developments
- 12.12 Biometrix
- 12.12.1 Biometrix Company Information
- 12.12.2 Biometrix Business Overview
- 12.12.3 Biometrix Revenue in Pleural Effusions Treatment Business (2021-2026)
- 12.12.4 Biometrix Pleural Effusions Treatment Product Portfolio
- 12.12.5 Biometrix Recent Developments
- 12.13 Bicakcilar
- 12.13.1 Bicakcilar Company Information
- 12.13.2 Bicakcilar Business Overview
- 12.13.3 Bicakcilar Revenue in Pleural Effusions Treatment Business (2021-2026)
- 12.13.4 Bicakcilar Pleural Effusions Treatment Product Portfolio
- 12.13.5 Bicakcilar Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst